Physiological
 
Optimization
 
in
 
the
 
Endurance
 
Athlete:
 
A
 
Comprehensive
 
Analysis
 
of
 
Hematological
 
and
 
Endocrine
 
Biomarkers
 
1.
 
Introduction:
 
The
 
Divergence
 
of
 
Clinical
 
and
 
Athletic
 
Norms
 
The
 
physiological
 
demands
 
placed
 
upon
 
the
 
endurance
 
athlete
 
precipitate
 
a
 
cascade
 
of
 
adaptations
 
that
 
fundamentally
 
alter
 
the
 
baseline
 
biochemical
 
landscape
 
of
 
the
 
human
 
body.
 
High-volume
 
aerobic
 
training,
 
characterized
 
by
 
repetitive
 
high-force
 
eccentric
 
loading,
 
substantial
 
caloric
 
turnover,
 
and
 
sustained
 
sympathetic
 
nervous
 
system
 
activation,
 
creates
 
a
 
distinct
 
metabolic
 
phenotype.
 
Consequently,
 
the
 
interpretation
 
of
 
blood
 
biomarkers
 
in
 
this
 
population
 
requires
 
a
 
paradigm
 
shift
 
away
 
from
 
standard
 
clinical
 
reference
 
ranges—which
 
are
 
statistically
 
derived
 
from
 
a
 
sedentary,
 
general
 
population—toward
 
athlete-specific
 
optimal
 
ranges.
 
In
 
the
 
clinical
 
setting,
 
a
 
"normal"
 
result
 
often
 
signifies
 
the
 
absence
 
of
 
acute
 
pathology.
 
For
 
the
 
endurance
 
athlete,
 
however,
 
"normal"
 
may
 
represent
 
a
 
state
 
of
 
physiological
 
stagnation
 
or
 
sub-clinical
 
deficiency
 
that
 
serves
 
as
 
a
 
rate-limiting
 
factor
 
for
 
performance.
 
The
 
endurance
 
phenotype
 
presents
 
a
 
unique
 
diagnostic
 
challenge.
 
The
 
expansion
 
of
 
plasma
 
volume,
 
a
 
beneficial
 
adaptation
 
for
 
thermoregulation
 
and
 
cardiac
 
output,
 
frequently
 
mimics
 
anemia
 
through
 
hemodilution.
 
Skeletal
 
muscle
 
turnover
 
releases
 
enzymes
 
that
 
would
 
mimic
 
myocardial
 
infarction
 
or
 
trauma
 
in
 
a
 
non-athlete.
 
Furthermore,
 
the
 
endocrine
 
system
 
operates
 
on
 
a
 
delicate
 
axis
 
where
 
the
 
drive
 
for
 
anabolic
 
repair
 
must
 
constantly
 
counterbalance
 
catabolic
 
stress.
 
The
 
failure
 
to
 
recognize
 
these
 
nuances
 
leads
 
to
 
the
 
"healthy
 
sick"
 
paradox,
 
where
 
athletes
 
complaining
 
of
 
fatigue,
 
performance
 
plateaus,
 
or
 
poor
 
recovery
 
are
 
dismissed
 
by
 
general
 
practitioners
 
because
 
their
 
biomarkers
 
fall
 
within
 
the
 
broad
 
chasm
 
of
 
population
 
norms.
 
This
 
report
 
serves
 
as
 
an
 
exhaustive
 
examination
 
of
 
the
 
hematological
 
and
 
endocrine
 
biomarkers
 
critical
 
to
 
endurance
 
performance.
 
By
 
synthesizing
 
data
 
from
 
sports
 
endocrinology
 
and
 
hematology,
 
we
 
establish
 
optimal
 
stratifications
 
for
 
iron
 
status,
 
erythropoietic
 
capacity,
 
inflammatory
 
modulation,
 
and
 
hormonal
 
balance.
 
The
 
objective
 
is
 
to
 
define
 
the
 
biological
 
parameters
 
that
 
support
 
not
 
merely
 
health,
 
but
 
the
 
maximal
 
expression
 
of
 
human
 
endurance
 
potential.
 
2.
 
Iron
 
Metabolism:
 
The
 
Foundation
 
of
 
Aerobic
 

---PAGE---

Capacity
 
Iron
 
status
 
represents
 
the
 
single
 
most
 
volatile
 
and
 
consequential
 
variable
 
in
 
the
 
hematological
 
profile
 
of
 
the
 
endurance
 
athlete.
 
While
 
traditional
 
medicine
 
prioritizes
 
iron
 
primarily
 
for
 
its
 
role
 
in
 
hemoglobin
 
synthesis
 
and
 
oxygen
 
transport,
 
sports
 
hematology
 
recognizes
 
a
 
dual
 
function:
 
iron
 
is
 
a
 
non-negotiable
 
cofactor
 
for
 
the
 
mitochondrial
 
enzymes
 
that
 
drive
 
oxidative
 
phosphorylation.
 
2.1
 
The
 
Spectrum
 
of
 
Iron
 
Deficiency:
 
Beyond
 
Anemia
 
A
 
critical
 
limitation
 
in
 
standard
 
sports
 
medical
 
practice
 
is
 
the
 
binary
 
classification
 
of
 
iron
 
status
 
as
 
either
 
"anemic"
 
or
 
"normal."
 
This
 
dichotomy
 
ignores
 
the
 
existence
 
of
 
Iron
 
Deficiency
 
Non-Anemia
 
(IDNA)
,
 
a
 
prevalent
 
condition
 
where
 
iron
 
stores
 
are
 
depleted
 
despite
 
preserved
 
hemoglobin
 
concentrations.
 
Research
 
indicates
 
that
 
IDNA
 
is
 
a
 
distinct
 
clinical
 
entity
 
that
 
severely
 
hampers
 
endurance
 
output
 
through
 
mechanisms
 
independent
 
of
 
oxygen
 
delivery.
1
 
The
 
performance
 
decrements
 
associated
 
with
 
IDNA
 
are
 
mediated
 
by
 
the
 
downregulation
 
of
 
iron-dependent
 
mitochondrial
 
enzymes,
 
specifically
 
NADH
 
dehydrogenase,
 
citrate
 
synthase,
 
and
 
cytochrome
 
c
 
oxidase.
 
These
 
enzymes
 
are
 
essential
 
for
 
the
 
electron
 
transport
 
chain
 
and
 
the
 
efficient
 
oxidation
 
of
 
substrates.
 
When
 
serum
 
ferritin—the
 
primary
 
surrogate
 
for
 
iron
 
storage—falls
 
below
 
critical
 
thresholds,
 
the
 
body
 
prioritizes
 
erythropoiesis
 
over
 
tissue
 
iron
 
storage
 
to
 
maintain
 
immediate
 
survival
 
(oxygen
 
transport).
 
Consequently,
 
mitochondrial
 
efficiency
 
declines
 
before
 
hemoglobin
 
levels
 
drop.
1
 
This
 
mitochondrial
 
impairment
 
forces
 
a
 
premature
 
reliance
 
on
 
anaerobic
 
glycolysis
 
for
 
energy
 
production.
 
Athletes
 
with
 
IDNA
 
exhibit
 
higher
 
blood
 
lactate
 
concentrations
 
at
 
submaximal
 
workloads
 
and
 
a
 
reduced
 
time
 
to
 
exhaustion
 
compared
 
to
 
iron-replete
 
peers,
 
despite
 
having
 
identical
 
hemoglobin
 
levels.
1
 
A
 
pivotal
 
study
 
involving
 
165
 
female
 
collegiate
 
rowers
 
demonstrated
 
that
 
athletes
 
with
 
ferritin
 
levels
 
below
 
20
 
ng/mL
 
were,
 
on
 
average,
 
21
 
seconds
 
slower
 
over
 
a
 
2-kilometer
 
time
 
trial
 
than
 
those
 
with
 
normal
 
iron
 
stores.
1
 
Notably,
 
performance
 
improvements
 
were
 
statistically
 
significant
 
when
 
ferritin
 
was
 
repleted
 
to
 
just
 
25
 
ng/mL,
 
reinforcing
 
that
 
the
 
"normal"
 
clinical
 
floor
 
(often
 
12
 
ng/mL)
 
is
 
functionally
 
deficient
 
for
 
high-output
 
aerobic
 
metabolism.
2
 
2.2
 
Ferritin
 
Stratification
 
and
 
Athlete-Specific
 
Reference
 
Ranges
 
Ferritin
 
exists
 
on
 
a
 
metabolic
 
continuum.
 
To
 
optimize
 
performance,
 
clinicians
 
must
 
move
 
beyond
 
the
 
exclusion
 
of
 
pathology
 
(Stage
 
1)
 
and
 
target
 
the
 
optimization
 
of
 
storage
 
(Stage
 
3).
 
Stage
 
1:
 
Iron
 
Deficiency
 
Anemia
 
(IDA):
 
Characterized
 
by
 
depleted
 
iron
 
stores
 
(Ferritin
 
<12
 
ng/mL)
 
and
 
compromised
 
hemoglobin
 
synthesis
 
(Hb
 
<12
 
g/dL
 
for
 
women,
 
<13
 
g/dL
 
for
 
men).
 
This
 
stage
 
presents
 
with
 
overt
 
clinical
 
symptoms
 
including
 
pallor,
 
shortness
 
of
 
breath,
 
and
 
tachycardia.
3
 
Stage
 
2:
 
Iron
 
Deficiency
 
Non-Anemia
 
(IDNA):
 
Characterized
 
by
 
low
 
ferritin
 
(<30
 
ng/mL)
 
with
 
normal
 
hemoglobin.
 
This
 
is
 
the
 
"silent"
 
killer
 
of
 
performance,
 
where
 
athletes
 
experience
 
unexplained
 
fatigue,
 
poor
 
recovery,
 
and
 
stagnated
 
race
 
times.
 
The
 
physiological
 
disconnect
 

---PAGE---

lies
 
in
 
the
 
maintenance
 
of
 
oxygen
 
transport
 
(normal
 
Hb)
 
coupled
 
with
 
the
 
failure
 
of
 
oxygen
 
utilization
 
(mitochondrial
 
enzyme
 
dysfunction).
1
 
Stage
 
3:
 
Suboptimal
 
Iron
 
Stores:
 
Ferritin
 
levels
 
between
 
30
 
and
 
50
 
ng/mL.
 
While
 
clinically
 
acceptable,
 
these
 
levels
 
provide
 
an
 
insufficient
 
buffer
 
against
 
the
 
high
 
iron
 
turnover
 
inherent
 
in
 
heavy
 
training
 
blocks.
 
Athletes
 
in
 
this
 
range
 
are
 
at
 
high
 
risk
 
of
 
slipping
 
into
 
IDNA
 
during
 
periods
 
of
 
intensified
 
training
 
or
 
altitude
 
exposure.
1
 
Table
 
1:
 
Comparative
 
Ferritin
 
Reference
 
Ranges
 
 
Category
 
Clinical
 
Norm
 
(General
 
Population)
 
Athletic
 
Deficiency
 
Threshold
 
Optimal
 
Endurance
 
Range
 
Physiological
 
Rationale
 
Female
 
Ferritin
 
12
 
–
 
150
 
ng/mL
 
<
 
30
 
ng/mL
 
40
 
–
 
100+
 
ng/mL
 
Prevention
 
of
 
IDNA;
 
support
 
for
 
oxidative
 
enzymes.
1
 
Male
 
Ferritin
 
12
 
–
 
300
 
ng/mL
 
<
 
40
 
ng/mL
 
50
 
–
 
150+
 
ng/mL
 
Higher
 
turnover
 
due
 
to
 
impact
 
hemolysis
 
and
 
sweat
 
loss.
1
 
Clinical
 
Implication
 
Rule
 
out
 
pathology.
 
Detect
 
performance
 
limiter.
 
Ensure
 
training
 
resilience.
 
 
Elite
 
endurance
 
monitoring
 
suggests
 
maintaining
 
ferritin
 
above
 
50
 
ng/mL
 
serves
 
as
 
a
 
"metabolic
 
insurance
 
policy,"
 
ensuring
 
that
 
enzymatic
 
processes
 
are
 
never
 
rate-limited
 
by
 
substrate
 
availability.
4
 
2.3
 
Mechanisms
 
of
 
Accelerated
 
Iron
 
Loss
 
The
 
endurance
 
athlete
 
acts
 
as
 
an
 
open
 
system
 
for
 
iron
 
loss,
 
losing
 
the
 
mineral
 
through
 
pathways
 
that
 
are
 
physiologically
 
negligible
 
in
 
sedentary
 
individuals.
 
Foot-Strike
 
Hemolysis
 
(March
 
Hemoglobinuria):
 
The
 
repetitive,
 
high-impact
 
forces
 
generated
 
during
 
running
 
compress
 
the
 
capillaries
 
in
 
the
 
soles
 
of
 
the
 
feet,
 
mechanically
 
rupturing
 
erythrocytes.
 
This
 
releases
 
free
 
hemoglobin
 
into
 
the
 
plasma.
 
While
 
haptoglobin
 
scavenges
 
this
 
free
 
hemoglobin
 
to
 
recycle
 
the
 
iron,
 
the
 
system
 
can
 
become
 
saturated,
 
leading
 
to
 
the
 
loss
 
of
 
hemoglobin
 
in
 
the
 
urine
 
(hemoglobinuria).
5
 
Research
 
on
 
100-km
 
ultra-marathon
 
runners
 
showed
 
a
 
massive
 
2.5-fold
 
decrease
 
in
 
serum
 
haptoglobin
 
and
 
a
 
concomitant
 
rise
 
in
 
plasma
 
free
 
hemoglobin,
 
confirming
 
significant
 
intravascular
 
hemolysis.
7
 
While
 
often
 
transient,
 
chronic
 
foot-strike
 
hemolysis
 
creates
 
a
 
persistent
 
drain
 
on
 
iron
 
stores
 
that
 
bone
 
marrow
 
activity
 
must
 
constantly
 
counteract.
 
Gastrointestinal
 
and
 
Sudorific
 
Losses:
 
Ischemia
 
of
 
the
 
gastrointestinal
 
tract
 
during
 
prolonged
 
exertion
 
can
 
lead
 
to
 
transient
 
permeability
 
and
 
occult
 
blood
 
loss.
 
Furthermore,
 
iron
 
is
 
excreted
 
in
 
sweat;
 
athletes
 
training
 
in
 
hot
 
environments
 
with
 
high
 
sweat
 
rates
 
can
 
lose
 
significant
 
milligrams
 
of
 
iron
 
over
 
a
 
training
 
cycle.
8
 

---PAGE---

The
 
Hepcidin
 
Block:
 
Perhaps
 
the
 
most
 
critical
 
regulator
 
of
 
iron
 
status
 
in
 
athletes
 
is
 
hepcidin
,
 
a
 
peptide
 
hormone
 
synthesized
 
by
 
the
 
liver.
 
Hepcidin
 
serves
 
as
 
the
 
"master
 
switch"
 
for
 
iron
 
homeostasis,
 
functioning
 
to
 
inhibit
 
ferroportin—the
 
channel
 
responsible
 
for
 
transporting
 
iron
 
from
 
enterocytes
 
(gut
 
absorption)
 
and
 
macrophages
 
(recycling)
 
into
 
the
 
bloodstream.
 
Hepcidin
 
expression
 
is
 
notably
 
upregulated
 
by
 
Interleukin-6
 
(IL-6),
 
an
 
inflammatory
 
cytokine
 
released
 
in
 
response
 
to
 
muscle
 
damage
 
and
 
glycogen
 
depletion.
1
 
Following
 
an
 
intense
 
endurance
 
bout,
 
IL-6
 
levels
 
spike,
 
triggering
 
a
 
subsequent
 
rise
 
in
 
hepcidin
 
that
 
peaks
 
3–6
 
hours
 
post-exercise.
 
During
 
this
 
window,
 
the
 
athlete
 
enters
 
a
 
state
 
of
 
functional
 
iron
 
malabsorption;
 
oral
 
iron
 
supplements
 
taken
 
during
 
this
 
"hepcidin
 
block"
 
are
 
largely
 
unabsorbed.
1
 
This
 
mechanism
 
explains
 
why
 
many
 
athletes
 
remain
 
iron
 
deficient
 
despite
 
supplementation.
 
The
 
strategic
 
timing
 
of
 
iron
 
intake—specifically
 
avoiding
 
the
 
post-exercise
 
inflammatory
 
window
 
and
 
prioritizing
 
morning
 
intake
 
or
 
ingestion
 
on
 
rest
 
days—is
 
essential
 
for
 
therapeutic
 
efficacy.
 
3.
 
Erythropoiesis
 
and
 
Oxygen
 
Transport
 
Dynamics
 
While
 
iron
 
provides
 
the
 
enzymatic
 
machinery,
 
the
 
erythrocyte
 
(red
 
blood
 
cell)
 
remains
 
the
 
vehicle
 
for
 
oxygen
 
delivery.
 
The
 
hematological
 
profile
 
of
 
the
 
endurance
 
athlete
 
is
 
characterized
 
by
 
dynamic
 
shifts
 
in
 
plasma
 
volume
 
and
 
cell
 
turnover
 
that
 
frequently
 
confound
 
standard
 
diagnosis.
 
3.1
 
Dilutional
 
Pseudo-Anemia:
 
An
 
Adaptive
 
Response
 
One
 
of
 
the
 
most
 
frequent
 
misdiagnoses
 
in
 
sports
 
medicine
 
is
 
"Sports
 
Anemia."
 
Endurance
 
training
 
induces
 
a
 
rapid
 
and
 
substantial
 
expansion
 
of
 
plasma
 
volume,
 
mediated
 
by
 
the
 
renin-angiotensin-aldosterone
 
system
 
and
 
albumin
 
retention.
 
This
 
expansion
 
is
 
a
 
favorable
 
adaptation
 
that
 
enhances
 
thermoregulatory
 
capacity
 
(sweating)
 
and
 
increases
 
stroke
 
volume
 
via
 
the
 
Frank-Starling
 
mechanism.
6
 
However,
 
this
 
plasma
 
expansion
 
often
 
outpaces
 
the
 
synthesis
 
of
 
new
 
red
 
blood
 
cells
 
(erythropoiesis),
 
leading
 
to
 
a
 
hemodilution
 
effect.
 
An
 
athlete
 
may
 
present
 
with
 
hemoglobin
 
and
 
hematocrit
 
values
 
at
 
the
 
lower
 
end
 
of
 
the
 
clinical
 
range
 
(e.g.,
 
Hb
 
11.5
 
g/dL
 
in
 
a
 
female,
 
13.5
 
g/dL
 
in
 
a
 
male)
 
despite
 
having
 
a
 
normal
 
or
 
even
 
elevated
 
total
 
red
 
cell
 
mass
.
5
 
Differentiation
 
from
 
True
 
Anemia:
 
Differentiating
 
dilutional
 
pseudo-anemia
 
from
 
true
 
pathophysiology
 
requires
 
a
 
multi-parametric
 
approach.
 
●
 
True
 
Anemia:
 
Characterized
 
by
 
low
 
Hb,
 
low
 
hematocrit,
 
low
 
ferritin
,
 
and
 
microcytic/hypochromic
 
indices
 
(low
 
MCV/MCH).
 
It
 
represents
 
a
 
failure
 
of
 
production.
6
 
●
 
Pseudo-Anemia:
 
Characterized
 
by
 
low/normal
 
Hb,
 
low
 
hematocrit,
 
but
 
normal
 
ferritin
 
and
 
normocytic
 
indices.
 
Crucially,
 
performance
 
is
 
maintained
 
or
 
improved
 
due
 
to
 
the
 
enhanced
 
cardiac
 
output
 
associated
 
with
 
hypervolemia.
9
 
3.2
 
Hematocrit:
 
The
 
Viscosity
 
Trade-Off
 
Hematocrit
 
(Hct),
 
representing
 
the
 
volume
 
percentage
 
of
 
red
 
blood
 
cells
 
in
 
blood,
 
is
 
subject
 
to
 

---PAGE---

a
 
physiological
 
"sweet
 
spot."
 
While
 
artificially
 
elevating
 
hematocrit
 
(e.g.,
 
via
 
Erythropoietin
 
doping)
 
increases
 
oxygen-carrying
 
capacity,
 
it
 
simultaneously
 
increases
 
blood
 
viscosity.
 
According
 
to
 
Poiseuille's
 
Law,
 
increased
 
viscosity
 
increases
 
resistance
 
to
 
flow,
 
potentially
 
elevating
 
cardiac
 
workload
 
and
 
reducing
 
microcirculatory
 
perfusion.
10
 
In
 
elite
 
cohorts,
 
the
 
optimal
 
hematocrit
 
is
 
often
 
lower
 
than
 
intuitively
 
expected.
 
A
 
study
 
of
 
77
 
professional
 
footballers
 
revealed
 
that
 
athletes
 
in
 
the
 
lowest
 
quintile
 
of
 
hematocrit
 
(<40%)
 
possessed
 
higher
 
aerobic
 
working
 
capacities
 
compared
 
to
 
those
 
with
 
higher
 
levels.
10
 
This
 
paradox
 
underscores
 
the
 
dominance
 
of
 
plasma
 
volume
 
expansion
 
and
 
stroke
 
volume
 
in
 
determining
 
VO2
 
max,
 
rather
 
than
 
hemoglobin
 
concentration
 
alone.
 
However,
 
strict
 
upper
 
limits
 
are
 
enforced
 
in
 
competitive
 
sports
 
to
 
deter
 
doping
 
(e.g.,
 
UCI
 
limits
 
of
 
50%
 
for
 
men,
 
47%
 
for
 
women).
 
It
 
is
 
notable
 
that
 
altitude
 
residents
 
("highlanders")
 
naturally
 
maintain
 
higher
 
hematocrits
 
(often
 
>50%)
 
due
 
to
 
chronic
 
hypoxic
 
exposure,
 
confounding
 
these
 
regulatory
 
limits.
11
 
For
 
the
 
sea-level
 
athlete,
 
a
 
hematocrit
 
maintained
 
between
 
42–48%
 
(men)
 
and
 
38–44%
 
(women)
 
appears
 
to
 
balance
 
oxygen
 
capacity
 
with
 
optimal
 
rheology.
 
3.3
 
Vitamin
 
B12
 
and
 
the
 
Optimization
 
of
 
Erythropoiesis
 
Vitamin
 
B12
 
(cobalamin)
 
and
 
folate
 
are
 
critical
 
cofactors
 
for
 
DNA
 
synthesis
 
during
 
the
 
rapid
 
division
 
of
 
erythroid
 
precursors
 
in
 
the
 
bone
 
marrow.
 
Deficiency
 
leads
 
to
 
megaloblastic
 
anemia,
 
characterized
 
by
 
large,
 
fragile
 
red
 
blood
 
cells
 
(high
 
MCV).
 
However,
 
in
 
the
 
athletic
 
population,
 
the
 
goal
 
is
 
not
 
merely
 
avoiding
 
megaloblastosis
 
but
 
optimizing
 
the
 
rate
 
of
 
erythropoiesis
 
to
 
match
 
the
 
accelerated
 
turnover
 
caused
 
by
 
hemolysis.
 
Recent
 
investigations
 
into
 
elite
 
athletic
 
populations
 
suggest
 
that
 
the
 
optimal
 
Vitamin
 
B12
 
range
 
is
 
significantly
 
higher
 
than
 
the
 
clinical
 
norm.
 
A
 
comprehensive
 
study
 
of
 
Polish
 
elite
 
athletes
 
demonstrated
 
a
 
significant
 
positive
 
correlation
 
between
 
Vitamin
 
B12
 
concentrations
 
and
 
hemoglobin
 
formation
 
up
 
to
 
a
 
threshold
 
of
 
approximately
 
400
 
pg/mL
.
 
Above
 
700
 
pg/mL,
 
no
 
further
 
benefits
 
in
 
hemoglobin
 
synthesis
 
were
 
observed.
12
 
Standard
 
laboratory
 
reference
 
ranges
 
often
 
classify
 
deficiency
 
only
 
below
 
200
 
pg/mL.
 
This
 
leaves
 
a
 
vast
 
"gray
 
zone"
 
(200–400
 
pg/mL)
 
where
 
an
 
athlete
 
is
 
clinically
 
"normal"
 
but
 
physiologically
 
compromised
 
in
 
their
 
ability
 
to
 
maximize
 
red
 
cell
 
production.
 
Athletes
 
in
 
this
 
range
 
may
 
experience
 
suboptimal
 
recovery
 
from
 
hemolytic
 
stress.
 
Recommendation:
 
Endurance
 
athletes
 
should
 
target
 
Vitamin
 
B12
 
levels
 
between
 
400–700
 
pg/mL
.
 
Levels
 
below
 
400
 
pg/mL
 
warrant
 
nutritional
 
intervention,
 
even
 
in
 
the
 
absence
 
of
 
neurological
 
symptoms
 
or
 
macrocytosis.
12
 
4.
 
Muscular
 
Integrity
 
and
 
Inflammatory
 
Status
 
The
 
measurement
 
of
 
muscle
 
damage
 
biomarkers
 
provides
 
a
 
window
 
into
 
the
 
structural
 
toll
 
of
 
training.
 
However,
 
the
 
interpretation
 
of
 
these
 
markers
 
requires
 
a
 
specific
 
understanding
 
of
 
the
 
athlete's
 
"new
 
normal"
 
regarding
 
enzyme
 
kinetics.
 
4.1
 
Creatine
 
Kinase
 
(CK)
 
and
 
the
 
Rhabdomyolysis
 
Spectrum
 
Creatine
 
Kinase
 
(CK)
 
is
 
an
 
enzyme
 
found
 
in
 
the
 
heart,
 
brain,
 
and
 
skeletal
 
muscle.
 
Leakage
 
of
 

---PAGE---

CK
 
into
 
the
 
bloodstream
 
serves
 
as
 
a
 
proxy
 
for
 
muscle
 
membrane
 
disruption.
 
In
 
the
 
general
 
population,
 
CK
 
levels
 
>500
 
U/L
 
often
 
trigger
 
investigations
 
for
 
myopathy
 
or
 
cardiac
 
events.
 
In
 
endurance
 
athletes,
 
particularly
 
those
 
involved
 
in
 
eccentric
 
loading
 
(e.g.,
 
downhill
 
running),
 
CK
 
levels
 
can
 
transiently
 
exceed
 
20,000
 
U/L
 
without
 
indicating
 
renal
 
failure
 
or
 
permanent
 
damage.
15
 
Exertional
 
Rhabdomyolysis
 
vs.
 
Benign
 
Exertional
 
Hyper-CKemia:
 
The
 
distinction
 
between
 
benign
 
CK
 
elevation
 
and
 
pathological
 
rhabdomyolysis
 
is
 
critical.
 
●
 
Benign
 
Elevation:
 
CK
 
levels
 
may
 
rise
 
to
 
1,000–50,000
 
U/L
 
post-ultramarathon.
 
In
 
the
 
absence
 
of
 
myoglobinuria
 
(cola-colored
 
urine)
 
and
 
renal
 
dysfunction
 
(normal
 
creatinine),
 
this
 
is
 
a
 
physiological
 
consequence
 
of
 
extreme
 
exertion.
 
Clearance
 
typically
 
occurs
 
within
 
3–7
 
days.
15
 
●
 
Clinical
 
Rhabdomyolysis:
 
Defined
 
not
 
just
 
by
 
CK,
 
but
 
by
 
the
 
presence
 
of
 
myoglobinuria,
 
electrolyte
 
imbalances
 
(hyperkalemia),
 
and
 
acute
 
kidney
 
injury
 
(AKI).
 
The
 
McMahon
 
Score
 
is
 
a
 
validated
 
tool
 
for
 
assessing
 
the
 
risk
 
of
 
renal
 
failure
 
in
 
rhabdomyolysis,
 
prioritizing
 
factors
 
like
 
age,
 
gender,
 
and
 
initial
 
creatinine
 
over
 
absolute
 
CK
 
values.
17
 
Return
 
to
 
Training:
 
Guidelines
 
suggest
 
that
 
athletes
 
with
 
uncomplicated
 
exertional
 
rhabdomyolysis
 
(CK
 
<5x
 
Upper
 
Limit
 
of
 
Normal
 
(ULN)
 
within
 
72
 
hours,
 
no
 
renal
 
injury)
 
can
 
begin
 
a
 
graded
 
return
 
to
 
activity.
 
High-risk
 
athletes
 
(CK
 
remaining
 
elevated
 
>2
 
weeks,
 
history
 
of
 
AKI)
 
require
 
nephrology
 
clearance.
 
A
 
baseline
 
CK
 
assessment
 
is
 
recommended
 
for
 
all
 
athletes,
 
as
 
black
 
athletes
 
and
 
those
 
with
 
greater
 
muscle
 
mass
 
may
 
have
 
resting
 
CK
 
levels
 
up
 
to
 
3-5
 
times
 
higher
 
than
 
white/low-muscle
 
mass
 
counterparts,
 
skewing
 
interpretation.
18
 
4.2
 
High-Sensitivity
 
CRP
 
(hs-CRP)
 
as
 
a
 
Recovery
 
Barometer
 
While
 
CK
 
reflects
 
structural
 
damage,
 
High-Sensitivity
 
C-Reactive
 
Protein
 
(hs-CRP)
 
quantifies
 
systemic
 
inflammation.
 
hs-CRP
 
is
 
an
 
acute-phase
 
reactant
 
synthesized
 
by
 
the
 
liver
 
in
 
response
 
to
 
IL-6.
 
Unlike
 
standard
 
CRP,
 
which
 
detects
 
infection,
 
hs-CRP
 
is
 
sensitive
 
enough
 
to
 
detect
 
low-grade
 
inflammatory
 
states
 
associated
 
with
 
cardiovascular
 
risk
 
and
 
overtraining.
 
Acute
 
vs.
 
Chronic
 
Response:
 
●
 
Acute:
 
Following
 
an
 
endurance
 
bout
 
(e.g.,
 
a
 
marathon),
 
hs-CRP
 
levels
 
transiently
 
spike,
 
often
 
peaking
 
at
 
24
 
hours
 
post-exercise.
 
This
 
inflammation
 
is
 
a
 
necessary
 
signal
 
for
 
adaptation
 
and
 
tissue
 
remodeling.
19
 
●
 
Chronic:
 
A
 
persistently
 
elevated
 
baseline
 
hs-CRP
 
(>3.0
 
mg/L)
 
in
 
a
 
rested
 
state
 
is
 
a
 
maladaptive
 
sign.
 
It
 
correlates
 
with
 
non-functional
 
overreaching,
 
poor
 
sleep
 
quality,
 
and
 
potentially
 
increased
 
cardiovascular
 
risk.
20
 
Optimal
 
Zones:
 
Healthy
 
athletes
 
should
 
aim
 
for
 
a
 
baseline
 
hs-CRP
 
of
 
<1.0
 
mg/L
.
 
Levels
 
between
 
1.0–3.0
 
mg/L
 
indicate
 
moderate
 
inflammatory
 
burden,
 
potentially
 
from
 
insufficient
 
recovery
 
or
 
lifestyle
 
factors
 
(diet,
 
stress).
 
Levels
 
>3.0
 
mg/L
 
(in
 
the
 
absence
 
of
 
acute
 
infection)
 
necessitate
 
a
 
reduction
 
in
 
training
 
load,
 
as
 
high
 
systemic
 
inflammation
 
blunts
 
the
 
anabolic
 
response
 
and
 
impairs
 
glycogen
 
resynthesis.
20
 
Table
 
2:
 
Inflammatory
 
Biomarker
 
Interpretation
 
Biomarker
 
Acute
 
Training
 
Chronic
 
Maladaptive
 
Clinical
 
Action
 

---PAGE---

Response
 
(24h)
 
Signal
 
Creatine
 
Kinase
 
(CK)
 
500
 
–
 
50,000
 
U/L
 
(Depending
 
on
 
duration/eccentricity)
 
Failure
 
to
 
return
 
to
 
baseline
 
after
 
72-96h
 
rest.
 
Assess
 
for
 
sub-clinical
 
myopathy
 
or
 
insufficient
 
recovery.
 
hs-CRP
 
Transient
 
spike
 
(0.5
 
->
 
5.0+
 
mg/L)
 
Resting
 
baseline
 
>
 
3.0
 
mg/L
 
Evaluate
 
sleep,
 
diet,
 
and
 
total
 
stress
 
load.
 
Haptoglobin
 
Decrease
 
(Consumption
 
via
 
hemolysis)
 
Chronic
 
suppression
 
(<10
 
mg/dL)
 
Investigate
 
iron
 
stores;
 
assess
 
running
 
mechanics/shoes.
 
5.
 
The
 
Endocrine
 
Axis:
 
Anabolic
 
vs.
 
Catabolic
 
Balance
 
The
 
endocrine
 
system
 
serves
 
as
 
the
 
primary
 
regulator
 
of
 
the
 
body's
 
response
 
to
 
training
 
stress.
 
The
 
balance
 
between
 
anabolic
 
hormones
 
(Testosterone,
 
HGH,
 
IGF-1)
 
and
 
catabolic
 
hormones
 
(Cortisol)
 
determines
 
whether
 
a
 
training
 
block
 
results
 
in
 
supercompensation
 
or
 
maladaptation.
 
5.1
 
The
 
Testosterone:Cortisol
 
(T:C)
 
Ratio
 
The
 
T:C
 
ratio
 
is
 
perhaps
 
the
 
most
 
validated
 
biomarker
 
for
 
monitoring
 
training
 
stress.
 
Testosterone
 
drives
 
protein
 
synthesis,
 
erythropoiesis,
 
and
 
glycogen
 
replenishment.
 
Cortisol,
 
while
 
necessary
 
for
 
mobilizing
 
fuel
 
during
 
exercise,
 
promotes
 
protein
 
catabolism
 
and
 
immune
 
suppression
 
when
 
chronically
 
elevated.
22
 
Defining
 
the
 
Threshold:
 
Research
 
established
 
by
 
Adlercreutz
 
and
 
confirmed
 
by
 
modern
 
sports
 
science
 
identifies
 
a
 
Free
 
Testosterone:Cortisol
 
Ratio
 
(FTCR)
 
decrease
 
of
 
>30%
 
relative
 
to
 
the
 
athlete's
 
individual
 
baseline
 
as
 
a
 
potent
 
predictor
 
of
 
Overtraining
 
Syndrome
 
(OTS).22
 
Furthermore,
 
an
 
absolute
 
FTCR
 
value
 
below
 
0.35
 
x
 
10^-3
 
(calculated
 
with
 
specific
 
units)
 
is
 
often
 
cited
 
as
 
a
 
threshold
 
for
 
a
 
catabolic
 
state.24
 
Table
 
3:
 
The
 
T:C
 
Ratio
 
Zones
 
Status
 
T:C
 
Profile
 
Physiological
 
Implication
 
Anabolic
 
/
 
Ready
 
Ratio
 
>
 
0.40
 
High
 
readiness
 
for
 
intensity;
 
optimal
 
protein
 
synthesis.
 
Maintenance
 
Ratio
 
0.35
 
–
 
0.40
 
Stable
 
adaptation;
 
adequate
 
recovery.
 
Functional
 
Overreaching
 
Ratio
 
decrease
 
<
 
30%
 
Acute
 
fatigue;
 
recovery
 
possible
 
with
 
standard
 
rest
 
days.
 
Overtraining
 
Risk
 
Ratio
 
decrease
 
>
 
30%
 
Profound
 
catabolic
 
state;
 
high
 
risk
 
of
 
OTS
 
and
 
infection.
 

---PAGE---

Chronic
 
endurance
 
training
 
(>60
 
miles/week)
 
is
 
associated
 
with
 
the
 
"Exercise-Hypogonadal
 
Male
 
Condition,"
 
characterized
 
by
 
lower
 
resting
 
testosterone
 
and
 
higher
 
cortisol
 
compared
 
to
 
sedentary
 
controls.
 
This
 
is
 
often
 
an
 
adaptive
 
mechanism
 
to
 
energy
 
conservation
 
rather
 
than
 
permanent
 
pathology,
 
but
 
it
 
places
 
the
 
athlete
 
at
 
higher
 
risk
 
for
 
bone
 
stress
 
injuries
 
and
 
anemia.
26
 
5.2
 
The
 
Somatotropic
 
Axis:
 
HGH,
 
IGF-1,
 
and
 
Sleep
 
Architecture
 
Human
 
Growth
 
Hormone
 
(HGH)
 
and
 
Insulin-like
 
Growth
 
Factor
 
1
 
(IGF-1)
 
are
 
central
 
to
 
connective
 
tissue
 
repair
 
(collagen
 
synthesis)
 
and
 
somatic
 
maintenance.
 
Unlike
 
testosterone,
 
HGH
 
secretion
 
is
 
highly
 
pulsatile,
 
making
 
single-point
 
blood
 
tests
 
unreliable
 
for
 
assessing
 
status.
 
Sleep-Dependent
 
Secretion:
 
The
 
majority
 
of
 
daily
 
HGH
 
output
 
(up
 
to
 
75%)
 
occurs
 
during
 
the
 
first
 
phase
 
of
 
Slow
 
Wave
 
Sleep
 
(SWS)
,
 
specifically
 
Stage
 
3
 
NREM
 
sleep,
 
shortly
 
after
 
sleep
 
onset.
28
 
Disruptions
 
in
 
sleep
 
architecture—common
 
in
 
athletes
 
due
 
to
 
travel,
 
caffeine
 
use,
 
or
 
pre-race
 
anxiety—severely
 
blunt
 
this
 
nocturnal
 
pulse.
 
While
 
acute
 
sleep
 
deprivation
 
can
 
paradoxically
 
augment
 
the
 
exercise-induced
 
GH
 
response
 
the
 
following
 
day,
 
the
 
net
 
anabolic
 
effect
 
is
 
negative
 
due
 
to
 
the
 
loss
 
of
 
the
 
massive
 
nocturnal
 
surge.
29
 
The
 
Role
 
of
 
Resistance
 
Training:
 
Chronic
 
endurance
 
training
 
often
 
leads
 
to
 
a
 
blunted
 
GH
 
response
 
to
 
exercise
 
due
 
to
 
tissue
 
desensitization.
 
However,
 
incorporating
 
Heavy
 
Resistance
 
Training
 
(HRT)
 
or
 
low-load
 
training
 
with
 
Blood
 
Flow
 
Restriction
 
(BFR)
 
has
 
been
 
shown
 
to
 
restore
 
the
 
GH
 
response
 
in
 
endurance
 
athletes.
30
 
The
 
mechanism
 
involves
 
the
 
accumulation
 
of
 
metabolites
 
(lactate,
 
protons)
 
and
 
afferent
 
neural
 
feedback,
 
triggering
 
a
 
robust
 
pituitary
 
release
 
of
 
GH.
 
This
 
highlights
 
the
 
endocrine
 
necessity
 
of
 
cross-training
 
for
 
the
 
endurance
 
athlete
 
to
 
maintain
 
anabolic
 
sensitivity.
 
IGF-1
 
as
 
a
 
Stable
 
Marker:
 
Because
 
HGH
 
fluctuates
 
rapidly,
 
IGF-1
 
(produced
 
in
 
the
 
liver
 
in
 
response
 
to
 
HGH)
 
serves
 
as
 
a
 
more
 
stable,
 
integrated
 
marker
 
of
 
anabolic
 
status.
 
Low
 
IGF-1
 
is
 
strongly
 
correlated
 
with
 
Relative
 
Energy
 
Deficiency
 
in
 
Sport
 
(RED-S)
 
and
 
is
 
a
 
predictive
 
factor
 
for
 
poor
 
bone
 
mineral
 
density.
31
 
6.
 
Metabolic
 
Health
 
and
 
RED-S
 
Relative
 
Energy
 
Deficiency
 
in
 
Sport
 
(RED-S)
 
describes
 
a
 
syndrome
 
of
 
impaired
 
physiological
 
function
 
caused
 
by
 
Low
 
Energy
 
Availability
 
(LEA).
 
When
 
energy
 
intake
 
is
 
insufficient
 
to
 
support
 
the
 
energy
 
expenditure
 
of
 
exercise,
 
the
 
body
 
downregulates
 
"non-essential"
 
processes
 
to
 
preserve
 
survival
 
functions
 
like
 
thermoregulation
 
and
 
locomotion.
33
 
6.1
 
Low
 
T3
 
Syndrome
 
(Non-Thyroidal
 
Illness)
 
One
 
of
 
the
 
earliest
 
and
 
most
 
sensitive
 
indicators
 
of
 
LEA
 
is
 
the
 
suppression
 
of
 
the
 
thyroid
 
axis.
 
This
 
manifests
 
as
 
Low
 
T3
 
Syndrome
.
 
The
 
body
 
decreases
 
the
 
conversion
 
of
 
T4
 
(thyroxine)
 
to
 
the
 
metabolically
 
active
 
T3
 
(triiodothyronine)
 
and
 
increases
 
conversion
 
to
 
Reverse
 
T3
 
(rT3),
 
an
 

---PAGE---

inactive
 
isomer.
31
 
In
 
endurance
 
athletes,
 
a
 
low
 
Free
 
T3
 
level—even
 
in
 
the
 
presence
 
of
 
a
 
normal
 
TSH—is
 
a
 
red
 
flag
 
for
 
chronic
 
under-fueling.
 
This
 
state
 
is
 
metabolically
 
protective
 
(reducing
 
caloric
 
burn)
 
but
 
performance-destructive,
 
leading
 
to
 
reduced
 
cardiac
 
contractility,
 
impaired
 
muscle
 
relaxation,
 
and
 
fatigue.
 
Emerging
 
models
 
suggest
 
that
 
low
 
carbohydrate
 
availability,
 
combined
 
with
 
high
 
cortisol,
 
specifically
 
inhibits
 
the
 
5'-deiodinase
 
enzyme
 
responsible
 
for
 
T4-to-T3
 
conversion.
34
 
6.2
 
Hypogonadotropic
 
Hypogonadism
 
RED-S
 
profoundly
 
impacts
 
reproductive
 
hormones.
 
The
 
hypothalamus
 
reduces
 
the
 
pulse
 
frequency
 
of
 
Gonadotropin-Releasing
 
Hormone
 
(GnRH),
 
leading
 
to
 
reduced
 
Luteinizing
 
Hormone
 
(LH)
 
and
 
Follicle-Stimulating
 
Hormone
 
(FSH).
 
●
 
Females:
 
Result
 
is
 
Functional
 
Hypothalamic
 
Amenorrhea
 
(FHA)
 
and
 
low
 
estrogen.
 
●
 
Males:
 
Result
 
is
 
low
 
testosterone
 
and
 
reduced
 
libido.
 
The
 
suppression
 
of
 
sex
 
hormones
 
is
 
the
 
primary
 
driver
 
of
 
bone
 
density
 
loss
 
in
 
RED-S.
 
Estrogen
 
and
 
testosterone
 
are
 
critical
 
for
 
inhibiting
 
osteoclasts
 
(bone
 
resorption).
 
When
 
these
 
hormones
 
are
 
suppressed
 
by
 
LEA,
 
bone
 
resorption
 
outpaces
 
formation,
 
drastically
 
increasing
 
the
 
risk
 
of
 
Bone
 
Stress
 
Injuries
 
(BSI).
35
 
7.
 
Micronutrients:
 
Structural
 
and
 
Metabolic
 
Catalysts
 
Micronutrients
 
act
 
as
 
the
 
cofactors
 
for
 
the
 
enzymatic
 
and
 
hormonal
 
processes
 
described
 
above.
 
Two
 
minerals—Vitamin
 
D
 
and
 
Magnesium—are
 
frequently
 
mismanaged
 
due
 
to
 
inadequate
 
testing
 
methodologies.
 
7.1
 
Vitamin
 
D:
 
The
 
50
 
ng/mL
 
Threshold
 
Vitamin
 
D
 
is
 
a
 
steroid
 
pro-hormone
 
essential
 
for
 
calcium
 
absorption
 
and
 
skeletal
 
integrity.
 
While
 
clinical
 
sufficiency
 
is
 
often
 
defined
 
as
 
>30
 
ng/mL,
 
this
 
level
 
is
 
insufficient
 
for
 
the
 
high-impact
 
endurance
 
athlete.
 
Epidemiological
 
data
 
from
 
collegiate
 
and
 
professional
 
athletes
 
indicates
 
a
 
linear
 
relationship
 
between
 
Vitamin
 
D
 
status
 
and
 
stress
 
fracture
 
risk.
 
Athletes
 
with
 
25(OH)D
 
levels
 
<40
 
ng/mL
 
exhibit
 
a
 
significantly
 
higher
 
incidence
 
of
 
bone
 
stress
 
injuries
 
compared
 
to
 
those
 
>40
 
ng/mL.
36
 
The
 
"optimal"
 
zone
 
for
 
athletic
 
performance—associated
 
with
 
peak
 
neuromuscular
 
function
 
and
 
maximal
 
bone
 
density
 
accrual—appears
 
to
 
be
 
>50
 
ng/mL
.
37
 
Furthermore,
 
acute
 
high-dose
 
Vitamin
 
D
 
supplementation
 
prior
 
to
 
ultra-endurance
 
events
 
has
 
been
 
shown
 
to
 
attenuate
 
biomarkers
 
of
 
bone
 
resorption
 
(e.g.,
 
CTX),
 
suggesting
 
a
 
protective
 
effect
 
against
 
the
 
catabolic
 
stress
 
of
 
racing.
38
 
7.2
 
Magnesium:
 
The
 
Intracellular
 
Blind
 
Spot
 
Magnesium
 
is
 
required
 
for
 
ATP
 
synthesis,
 
muscle
 
relaxation,
 
and
 
insulin
 
sensitivity.
 
Deficiency
 
leads
 
to
 
cramping,
 
arrhythmia,
 
and
 
fatigue.
 
However,
 
Serum
 
Magnesium
 
is
 
a
 
poor
 
diagnostic
 
tool.
 
Less
 
than
 
1%
 
of
 
total
 
body
 
magnesium
 
resides
 
in
 
the
 
blood,
 
and
 
the
 
body
 
will
 

---PAGE---

aggressively
 
leach
 
magnesium
 
from
 
bone
 
and
 
muscle
 
to
 
maintain
 
serum
 
homeostasis.
39
 
An
 
athlete
 
can
 
have
 
normal
 
serum
 
magnesium
 
while
 
suffering
 
from
 
severe
 
intracellular
 
depletion.
 
The
 
RBC
 
Magnesium
 
test,
 
which
 
measures
 
concentration
 
within
 
the
 
erythrocyte,
 
provides
 
a
 
more
 
accurate
 
reflection
 
of
 
tissue
 
stores
 
over
 
the
 
120-day
 
lifespan
 
of
 
the
 
cell.
 
Optimal
 
RBC
 
Magnesium
 
(typically
 
4.2–6.8
 
mg/dL)
 
supports
 
sustained
 
muscular
 
contraction
 
and
 
mitigates
 
the
 
oxidative
 
stress
 
of
 
endurance
 
training.
40
 
8.
 
Conclusion
 
and
 
Integrated
 
Biomarker
 
Model
 
The
 
physiological
 
management
 
of
 
the
 
endurance
 
athlete
 
requires
 
a
 
rejection
 
of
 
the
 
"normal."
 
Clinical
 
reference
 
ranges,
 
while
 
useful
 
for
 
detecting
 
disease,
 
often
 
mask
 
the
 
sub-clinical
 
deficiencies
 
that
 
cap
 
athletic
 
potential.
 
A
 
comprehensive
 
monitoring
 
strategy
 
must
 
integrate
 
the
 
following
 
athlete-specific
 
targets:
 
1.
 
Iron:
 
Target
 
Ferritin
 
>50
 
ng/mL
 
to
 
support
 
mitochondrial
 
respiration,
 
not
 
just
 
hemoglobin
 
synthesis.
 
Recognize
 
the
 
hepcidin
 
block
 
in
 
supplementation
 
timing.
 
2.
 
Erythropoiesis:
 
Target
 
Vitamin
 
B12
 
400–700
 
pg/mL
 
and
 
understand
 
that
 
low
 
hematocrit
 
may
 
reflect
 
beneficial
 
plasma
 
volume
 
expansion
 
rather
 
than
 
anemia.
 
3.
 
Inflammation:
 
Use
 
hs-CRP
 
(<1
 
mg/L)
 
and
 
CK
 
trends
 
to
 
gauge
 
recovery,
 
distinguishing
 
benign
 
exertional
 
elevation
 
from
 
maladaptive
 
inflammation.
 
4.
 
Hormones:
 
Monitor
 
the
 
T:C
 
Ratio
 
for
 
>30%
 
deviations
 
to
 
preempt
 
overtraining.
 
Prioritize
 
sleep
 
hygiene
 
to
 
maximize
 
the
 
HGH
 
pulse.
 
5.
 
Metabolic
 
Health:
 
Screen
 
for
 
Low
 
T3
 
and
 
sex
 
hormone
 
suppression
 
as
 
early
 
warning
 
signs
 
of
 
RED-S.
 
6.
 
Micronutrients:
 
Maintain
 
Vitamin
 
D
 
>50
 
ng/mL
 
and
 
utilize
 
RBC
 
Magnesium
 
for
 
accurate
 
electrolyte
 
assessment.
 
By
 
adhering
 
to
 
these
 
rigorous,
 
physiology-based
 
standards,
 
the
 
sports
 
endocrinologist
 
moves
 
beyond
 
the
 
role
 
of
 
treating
 
illness
 
and
 
into
 
the
 
realm
 
of
 
engineering
 
peak
 
performance.
 
The
 
data
 
does
 
not
 
merely
 
describe
 
the
 
athlete's
 
state;
 
it
 
prescribes
 
the
 
path
 
to
 
their
 
potential.
 
Appendix:
 
Summary
 
of
 
Athletic
 
vs.
 
Clinical
 
Reference
 
Ranges
 
 
Biomarker
 
Clinical
 
Norm
 
(General)
 
Athletic
 
Optimal
 
Range
 
Physiological
 
Rationale
 
Source
 
Ferritin
 
12
 
–
 
300
 
ng/mL
 
>
 
50
 
ng/mL
 
Mitochondrial
 
enzyme
 
saturation;
 
buffer
 
against
 
hemolysis.
 
1
 

---PAGE---

Vitamin
 
B12
 
200
 
–
 
900
 
pg/mL
 
400
 
–
 
700
 
pg/mL
 
Maximal
 
hemoglobin
 
synthesis
 
rate.
 
12
 
Vitamin
 
D
 
(25-OH)
 
>
 
30
 
ng/mL
 
>
 
50
 
ng/mL
 
Stress
 
fracture
 
prevention;
 
neuromuscular
 
function.
 
36
 
Hematocrit
 
(M)
 
41
 
–
 
50%
 
42
 
–
 
48%
 
Balance
 
of
 
O2
 
capacity
 
vs.
 
viscosity/rheology.
 
10
 
hs-CRP
 
<
 
3.0
 
mg/L
 
<
 
1.0
 
mg/L
 
Indication
 
of
 
full
 
systemic
 
recovery.
 
20
 
T:C
 
Ratio
 
N/A
 
>
 
0.35
 
Anabolic
 
dominance;
 
prevention
 
of
 
OTS.
 
24
 
Magnesium
 
Serum:
 
1.7–2.2
 
mg/dL
 
RBC
 
Mg:
 
4.2–6.8
 
mg/dL
 
Accurate
 
intracellular
 
ATP/electrolyte
 
status.
 
40
 
CK
 
(Resting)
 
<
 
200
 
U/L
 
<
 
300-500
 
U/L
 
Variable
 
by
 
muscle
 
mass/ethnicity;
 
trend
 
is
 
key.
 
18
 
Alıntılanan
 
çalışmalar
 
1.
 
Your
 
"Norm al"
 
Ferritin
 
Is
 
Killing
 
Your
 
Run ning
 
...
 
-
 
Run ners
 
Conne ct,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://runnersconnect.net/ferritin-levels/
 
2.
 
Iron
 
Deficiency
 
In
 
Runners,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://runnersconnect.net/iron-deficiency-in-runners/
 
3.
 
Low
 
ferritin
 
and
 
iron
 
deficiency
 
anem ia
 
in
 
distance
 
run ners:
 
A
 
scientific
 
guide
 
for
 
athletes
 
and
 
coaches
 
-
 
Lourdes
 
Academ y,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://lourdesacademyoshkosh.org/documents/2024/3/LowFerritin.pdf
 
4.
 
Team
 
Physician
 
Statem ent
 
on
 
Iron
 
Status
 
Screening
 
-
 
Carleton
 
College,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://athletics.carleton.edu/sports/2019/7/17/team-physician-statement-on-iron 
-status-screening.aspx?id=6017
 
5.
 
Runner's
 
anem ia
 
-
 
PubM ed,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pubmed.ncbi.nlm.nih.gov/11495622/
 
6.
 
Runner's
 
anem ia
 
-
 
Pathology
 
Student,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.pathologystudent.com/runners-anemia/
 
7.
 
Epidem iological,
 
biological
 
and
 
clinical
 
update
 
on
 
exercise-ind uced
 
hem olysis
 
-
 
Lippi,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://atm.amegroups.org/article/view/25989/html
 

---PAGE---

8.
 
Iron
 
Deficiency
 
in
 
Athletes:
 
Insights
 
for
 
Sports
 
Nutrition
 
-
 
Eur opean
 
Society
 
of
 
M edicine,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://esmed.org/iron-deficiency-in-athletes-insights-for-sports-nutrition/
 
9.
 
Anem ia
 
in
 
athletes
 
-
 
ResearchG ate,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.researchgate.net/publication/286577154_Anemia_in_athletes
 
10.
 
The
 
paradox
 
of
 
hem atocrit
 
in
 
exercise
 
physiology:
 
which
 
is
 
the
 
...,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pubmed.ncbi.nlm.nih.gov/11081466/
 
11.
 
(PDF)
 
Hem atocrit
 
levels
 
in
 
elite
 
athletes
 
-
 
ResearchG ate,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.researchgate.net/publication/288979238_Hematocrit_levels_in_elite_ 
athletes
 
12.
 
Vitam in
 
B12
 
Status
 
and
 
O ptim al
 
Range
 
for
 
Hem oglobin
 
Form ation
 
in
 
...,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC7230602/
 
13.
 
(PDF)
 
Vitam in
 
B12
 
Status
 
and
 
O ptim al
 
Range
 
for
 
Hem oglobin
 
Form ation
 
in
 
Elite
 
Athletes,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.researchgate.net/publication/340566793_Vitamin_B12_Status_and_O 
ptimal_Range_for_Hemoglobin_Formation_in_Elite_Athletes
 
14.
 
Vitam in
 
B12
 
Status
 
and
 
O ptim al
 
Range
 
for
 
Hem oglobin
 
Form ation
 
in
 
Elite
 
Athletes
 
-
 
PubM ed,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pubmed.ncbi.nlm.nih.gov/32283824/
 
15.
 
Let's
 
Break
 
It
 
Down:
 
Rhabdom yolysis
 
In
 
Ultram arathons
 
-
 
iRunF ar,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.irunfar.com/break-it-down-exertional-rhabdomyolysis-in-ultramarat 
hons
 
16.
 
How
 
can
 
I
 
prevent
 
getting
 
Rhabdo
 
again?
 
:
 
r/Ultram arathon
 
-
 
Reddit,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.reddit.com/r/Ultramarathon/comments/1n0xs0f/how_can_i_prevent_ 
getting_rhabdo_again/
 
17.
 
Rhabdom yolysis
 
-
 
EM Crit
 
Project,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://emcrit.org/ibcc/rhabdo/
 
18.
 
Approach
 
to
 
asym ptom atic
 
creatine
 
kinase
 
elevation
 
-
 
Cleveland
 
Clinic
 
Journal
 
of
 
M edicine,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.ccjm.org/content/83/1/37
 
19.
 
Inflam m atory
 
Effects
 
of
 
High
 
and
 
M oderate
 
Intens ity
 
Exercise— A
 
System atic
 
Review,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2019.01550 
/full
 
20.
 
Best
 
Biom arkers
 
to
 
M onitor
 
for
 
End uranc e
 
and
 
Recovery
 
|
 
Learn
 
W ith
 
Superpower,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://superpower.com/best-biomarkers/endurance-recovery
 
21.
 
C-Reactive
 
Protein,
 
Inflam m ation,
 
and
 
Cardiovascular
 
Disease:
 
Clinical
 
Update
 
-
 
PM C
 
-
 
NIH,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC1336715/
 
22.
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC12604835/#:~:text=While%20an%20abs 
olute%20value%20as,litre%20(nmol%2FL)%20and
 
23.
 
The
 
Testosterone:
 
Cortisol
 
Ratio
 
-
 
A
 
Tool
 
with
 
Practical
 
Use
 
and
 
Research
 

---PAGE---

Potential
 
in
 
Endocrinology
 
-
 
PubM ed
 
Central,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC12604835/
 
24.
 
Free
 
testosterone/cortisol
 
ratio
 
in
 
soccer:
 
Usefulne ss
 
of
 
a
 
categorization
 
of
 
values,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.researchgate.net/publication/6677586_Free_testosteronecortisol_rati 
o_in_soccer_Usefulness_of_a_categorization_of_values
 
25.
 
Could
 
a
 
high
 
Testosterone/Cortisol
 
ratio
 
indicate
 
an
 
ana bolic
 
state?
 
|
 
SiPhox
 
Health,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://siphoxhealth.com/articles/could-a-high-testosteronecortisol-ratio-indicat 
e-an-anabolic-state
 
26.
 
Could
 
a
 
low
 
Testosterone/Cortisol
 
ratio
 
indicate
 
chronic
 
stress
 
or
 
overtraining?,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://siphoxhealth.com/articles/could-a-low-testosteronecortisol-ratio-indicate 
-chronic-stress-or-overtraining
 
27.
 
Testosterone,
 
IG F-1,
 
and
 
HRT:
 
How
 
Horm one s
 
Im pact
 
End urance
 
Training,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://blog.accessmedlab.com/hormonal-balance-endurance-athletes
 
28.
 
Sleep
 
and
 
Hum an
 
G row th
 
Horm one
 
-
 
W arrior
 
Fitne ss
 
Adventur e,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.warriorfitnessadventure.com/sleep-and-human-growth-hormone/
 
29.
 
Exercise‐Induced
 
grow th
 
horm one
 
dur ing
 
acute
 
sleep
 
deprivation
 
-
 
PM C
 
-
 
PubM ed
 
Central,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC4254093/
 
30.
 
G row th
 
horm one
 
responses
 
to
 
acute
 
resistance
 
exercise
 
with
 
vascular
 
restriction
 
in
 
young
 
and
 
old
 
m en
 
-
 
PubM ed
 
Central,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC3915940/
 
31.
 
The
 
Fem ale
 
Athlete
 
Triad/Relative
 
Energy
 
Deficienc y
 
in
 
Sports
 
(RED-S)
 
-
 
PubM ed
 
Central,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC10304901/
 
32.
 
Type
 
of
 
training
 
has
 
a
 
significant
 
influence
 
on
 
the
 
G H/IG F-1
 
axis
 
but
 
not
 
on
 
regulating
 
m iRNAs
 
-
 
NIH,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC7433330/
 
33.
 
Relative
 
Energy
 
Deficiency
 
in
 
Sport
 
(REDs)
 
|
 
Boston
 
Children's
 
Hospital,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.childrenshospital.org/conditions/reds
 
34.
 
Low
 
Energy
 
Availability,
 
Carbohydrate
 
Intake,
 
and
 
Relative
 
Energy
 
Deficiency
 
in
 
Sport:
 
The
 
Low
 
Triiodothyronine
 
Hypothesis
 
in
 
-
 
Hum an
 
Kine tics
 
Journals,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://journals.humankinetics.com/view/journals/ijspp/aop/article-10.1123-ijspp.2 
025-0073/article-10.1123-ijspp.2025-0073.xml
 
35.
 
Relative
 
Energy
 
Deficiency
 
in
 
Sport
 
(RED-S)
 
-
 
Dyna M ed,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.dynamed.com/condition/relative-energy-deficiency-in-sport-red-s/P 
latformDynaAI
 
36.
 
Association
 
of
 
Serum
 
Vitam in
 
D
 
Levels
 
and
 
Stress
 
Fractures
 
in
 
Collegiate
 
Athletes
 
-
 
PM C,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 

---PAGE---

https://pmc.ncbi.nlm.nih.gov/articles/PMC8008136/
 
37.
 
Sports
 
Health
 
Benefits
 
of
 
Vitam in
 
D
 
-
 
PM C
 
-
 
NIH,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC3497950/
 
38.
 
Pre-race
 
vitam in
 
D
 
could
 
do
 
wonders
 
for
 
ultrarunne rs'
 
bone
 
health,
 
according
 
to
 
science,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.runnersworld.com/uk/health/injury/a68056833/vitamin-d-ultramarath 
on-study/
 
39.
 
M agnesium
 
the
 
Forgotten
 
M ineral
 
|
 
Asheville,
 
NC
 
Chiropractor
 
|
 
M yers
 
Chiropractic
 
&
 
Functional
 
Health,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://www.bmyerschiro.com/blog/magnesium-the-forgotten-mineral
 
40.
 
M agnesium
 
G ets
 
a
 
M akeover!
 
A
 
Brand
 
New
 
Biom arker
 
&
 
Better
 
O ptim ization,
 
erişim
 
tarihi
 
Aralık
 
3,
 
2025,
 
https://blog.insidetracker.com/magnesium-makeover-new-biomarker-better-opti 
mization
 

---PAGE---

